Mass Spectrometry Market to Hit USD 9.62 Billion by 2030 with 7.2% CAGR | MarketsandMarkets™
DELRAY BEACH, Fla., Feb. 4, 2025 /PRNewswire/ -- The Mass Spectrometry market valued at US$ 5.82 Billion in 2023, is forecasted...
Diagnostics
Axtria Harnesses GenAI to Slash Timelines and Boost Accuracy in Clinical Study Reporting with Axtria Rapid CSR
GenAI-powered solution delivers clinical study reports in minutes with 30%–50% faster turnarounds, 90% ICH-E3-aligned accuracy, and substantial cost savings. BERKELEY...
PathAssist Derm Launches on AISight®: Advancing Dermatopathology Research Workflows using AI
Now available on the AISight® Platform, PathAssist Derm is an AI-assisted histopathology tool that enhances dermatopathology research workflows, accelerating skin...
Moore Market analysis: Zero Candida potential market will reach over $2 Billion by 2030
According to the report: up to 75% of women will have at least one vaginal yeast infection in their life...
Lunit Partners with SITC to Launch Exclusive Research Program Featuring Advanced AI Technology for SITC Members
Lunit SCOPE® IO now available to SITC members for AI-powered TME profiling, in a collaborative effort to advance cancer immunotherapy...
InMode to Participate in the BTIG MedTech, Digital Health, Life Sciences & Diagnostics Tools Conference
YOKNEAM, Israel, Feb. 3, 2025 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, today...
Notal Vision Announces a Pivotal Study Demonstrating the Efficacy of AI in Enabling Home OCT Monitoring
Manassas, Virginia--(Newsfile Corp. - February 3, 2025) - Digital healthcare provider, Notal Vision, announced that the results of a pivotal...
Women in Science: Breaking Barriers with HNL Lab Medicine
ALLENTOWN, Pa., Jan. 31, 2025 (GLOBE NEWSWIRE) -- Women are still vastly underrepresented in science, technology, engineering, and math (STEM)...
Aclarion to Showcase Groundbreaking NOCISCAN Technology at the Selby Spine Conference
Dr. Sigurd Berven to Highlight NOCISCAN Capabilities, Combining MR Spectroscopy and Augmented Intelligence (AI) NOCISCAN as New Gold Standard in Identifying...
Roche receives FDA approval for the first companion diagnostic to identify patients with HER2-ultralow metastatic breast cancer eligible for ENHERTU
As seen in the DESTINY-Breast06 trial, approximately 20-25 percent of hormone receptor (HR)-positive, HER2-negative breast cancer patients may be considered...
Sleep Software Market to Hit USD 1,569.2 Million by 2030 with 10.1% CAGR | MarketsandMarkets™
DELRAY BEACH, Fla., Jan. 30, 2025 /PRNewswire/ -- The global sleep software market valued at US$ 776.2 Million in 2023, is forecasted...
VMX 2025: A Record-Breaking Celebration of Innovation, Education and Thought Leadership in Veterinary Medicine
Breakthroughs in veterinary medicine, immersive hands-on experiences and Academy Award-winning actor and director Kevin Costner headline the world's largest and...
Co-Diagnostics, Inc. to Exhibit at BioUtah’s 2025 Life Sciences Day on the Hill
SALT LAKE CITY, Jan. 30, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq-CM: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company...
Large clinical study establishes Nu.Q® NETs H3.1 as an independent predictor of 28-day mortality in sepsis
HENDERSON, Nev., Jan. 30, 2025 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, today announced the...
Top Product Development Firm Reports Record-Breaking Year Helping Companies Develop AI-Powered and Connected Hardware
OTTAWA, ON, Jan. 30, 2025 /PRNewswire/ - How one of the largest end-to-end product development firms in North America accelerated go-to-market...
Kansas City Metro Selected by Groundbreaking Australian Animal Health Tech Company for North American HQ
The animal health intelligence company, Ceres Tag, is expanding into the United States for the distribution of its first-of-its-kind direct-to-satellite...
Medrio’s Launches AI-Enabled Reporting, Tackling Increasing Data Challenges in Clinical Trials
SAN FRANCISCO, Jan. 29, 2025 /PRNewswire/ -- Medrio, a global leader in clinical trial technology, today announced the release of AI-enabled...
Danaher Reports Fourth Quarter and Full Year 2024 Results
WASHINGTON, Jan. 29, 2025 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) (the "Company") today announced results for the fourth quarter and...
Zentalis Pharmaceuticals Shares Updated Clinical Data Demonstrating Meaningful Azenosertib Activity in Cyclin E1+, Platinum-Resistant Ovarian Cancer
Results from DENALI Part 1b show an Objective Response Rate (ORR) of ~35% in response-evaluable, heavily-pretreated patients with Cyclin E1+...
Change to the Roche Enlarged Corporate Executive Committee
Basel, 29 January 2025 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that Wafaa Mamilli (1967) will join the company...